A Prospective Analysis of In Situ Simulation on Patient Safety and Experience in Community and Rural Emergency Departments

Overview

About this study

The purpose of this study is to evaluate whether in situ simulation (ISS) adversely effects patient safety by evaluating quantitative surrogate markers including patient wait times, irregular departure rates, and reported patient safety events.  We will also evaluate ED staff/patient perceptions of the impact of ISS on workflow and experience.  Our findings may improve ISS design or refine existing best-practices.

During in situ simulation (ISS), participants manage simulated patients within their typical clinical environments and multidisciplinary teams.  This approach improves realism and engagement, enhances learning, and makes the simulations more effective.  While ISS is known to improve patient safety through the detection of latent safety threats (LSTs) – previously unrecognized systems-based issues, the potential to disrupt or negative impact patient care actively occurring alongside the simulation is an underexplored area of risk.

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients ≥ 18 years of age.  If the patient is less than 18 years of age, their parent/guardian will be asked to complete the survey.
  • Patients who have registered to be seen during the ISS activity or within 20 minutes prior to the start of the ISS activity.
  • Patients will be approached when their disposition has been set (discharge/admit/transfer) by the treating clinician.
  • Non-native English speaking patients will be included if an interpreter is available to aid in survey completion.
  • Staff working clinically in the ED will be asked to complete a survey at the conclusion of the ISS activity.

Exclusion Criteria:

  • Patients < 18 years of age.
  • Patients who are too ill to participate or who are dispositioned after the simulation team departs.    

Eligibility last updated 6/28/23. Questions regarding updates should be directed to the study team contact.

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Albert Lea, Minn.

Mayo Clinic principal investigator

Jessica Schoen

Open for enrollment

Contact information:

Jessica Schoen

(507) 434-1488

Schoen.Jessica@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Jessica Schoen

Open for enrollment

Contact information:

Jessica Schoen

(507) 434-1488

Schoen.Jessica@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597045

Mayo Clinic Footer